📋 Simple Summary
Trigonelline is a natural compound found in coffee and fenugreek that is structurally a close cousin of niacin (vitamin B3). In 2024, a landmark study in the journal Nature Metabolism found that trigonelline is a genuine NAD⁺ booster — your body converts it into NAD⁺, the “fuel molecule” that powers your cells and declines as you age. Older adults with sarcopenia (age-related muscle loss) had lower trigonelline in their blood, and giving it to aging mice improved their muscle strength. But here’s the honest catch: the human evidence is still thin and mixed — one small food trial showed a benefit, another showed no benefit and a surprising rise in blood pressure. It’s promising, cheap, and you already get it from coffee — but it is not yet proven to slow human aging.
The detailed breakdown continues below for those who want the full science.
Published: August 17, 2026
Evidence Tier: 🥈 Silver — a landmark NAD⁺ mechanism paper in humans, worms, and mice, plus real animal longevity data, but no large human trial yet and one small trial raised a safety flag.
Category: 💊 Supplements & Compounds
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking trigonelline — especially if you take diabetes medication, blood-pressure medication, or blood thinners, or if you are pregnant or breastfeeding. The information below is for education only.
✅ Pros
- Real NAD⁺-boosting mechanism in humans: A 2024 Nature Metabolism study showed human cells, worms, and mice all convert trigonelline into NAD⁺ — via a different pathway from NMN and NR, so it’s a genuinely distinct route.
- Best evidence is for muscle aging: In aging mice, trigonelline improved muscle strength and reduced fatigue, and lower blood trigonelline tracked with worse muscle health in people.
- Actual lifespan data in worms: It extended roundworm lifespan by about 18% through conserved longevity pathways (AMPK, FOXO).
- Cheap, food-derived, well-tolerated: It’s a normal part of coffee, so most people already consume some daily with no issue.
❌ Cons
- No large human trial: Zero proof in humans that trigonelline supplements slow aging or build muscle — the human data is observational plus two small, short food trials.
- One human trial raised a safety flag: In people with metabolic syndrome, trigonelline-rich radish raised systolic blood pressure (~+9 mmHg) and oxidative stress — a real caution signal.
- Lifespan data is worms only: No mammal has lived longer on trigonelline; mice showed muscle benefit, not lifespan extension.
- Crowded field: As “another NAD⁺ precursor,” trigonelline competes with NMN, NR, and niacin — none of which has a proven human longevity edge either.
What Is Trigonelline?
Trigonelline is a pyridine alkaloid — a natural, nitrogen-containing plant compound. Chemically, it is nicotinic acid (niacin, or vitamin B3) with one extra “methyl group” attached. That one small chemical tag is the whole story: it makes trigonelline a storage-and-delivery form of niacin, and your body can strip the tag off and feed the niacin into the NAD⁺ production line.
It’s found in the highest amounts in coffee beans (especially Arabica), fenugreek seeds, and a few vegetables like peas, barley, corn, and spinach. It’s also unusually abundant in a giant Japanese root vegetable called the Sakurajima radish, which researchers now use as a natural “trigonelline pill” in human studies.
In the longevity world, trigonelline went from obscure to headline in 2024, when a team led by Mathieu Membrez and Jerome Feige at Nestlé Research (working with academic collaborators) published a landmark paper in Nature Metabolism showing it is a bona fide NAD⁺ precursor — the first new one to gain serious traction since NMN and NR.
How It Works
Trigonelline has a few distinct jobs, and they fit together.
1. It Boosts NAD⁺ Through a Different Door (the Preiss-Handler Pathway)
NAD⁺ is a coenzyme — a helper molecule — that every cell uses to make energy and repair DNA. Its levels fall with age, and low NAD⁺ is linked to muscle aging and metabolic decline. Most popular NAD⁺ supplements (NMN, NR) work through the “salvage pathway.” Trigonelline takes a different route: the body strips its methyl group to make nicotinic acid, which then enters NAD⁺ production through the Preiss-Handler pathway (named for its discoverers). The landmark 2024 study confirmed this using isotopically labeled trigonelline, showing the label landing inside NAD⁺ in human cells, worms, and mice (PMID 38504132). Because it uses a different enzyme (NAPRT) than NMN/NR, it’s a genuinely independent way to raise NAD⁺ — and it does not trigger the “niacin flush” because it doesn’t activate the GPR109A receptor.
2. It Depends on Sirtuins — the “Longevity Proteins”
Sirtuins are a family of proteins that switch on cell repair and stress resistance when NAD⁺ is abundant. In worms, trigonelline’s lifespan benefit required a working sirtuin gene — meaning it works through the classic NAD⁺-sirtuin longevity axis (PMID 38504132).
3. It Activates AMPK and FOXO — Conserved Longevity Switches
The first lifespan study found trigonelline’s worm benefit depended on aak-2 (AMPK), daf-16 (FOXO), and hsf-1 (a heat-shock/stress factor) — the same nutrient-sensing and stress-defense pathways that calorie restriction and metformin target (PMID 34616504).
4. It Turns On NRF2 — the Cell’s Antioxidant Master Switch
NRF2 is a protein that switches on your cells’ built-in antioxidant and detox defenses. Trigonelline transiently activates NRF2, which is how it protected egg quality in aging mice (PMID 41210958) and how it guards blood-vessel cells against high blood sugar (PMID 39191024).
5. It Quiets Inflammation
In a mouse model of accelerated brain aging, trigonelline reduced the inflammatory signals TNFα and IL-6 while raising the neurotransmitters dopamine, noradrenaline, and serotonin (PMID 37721682) — the same low-grade “inflammaging” that drives most age-related disease.
The Longevity Connection
Here’s what the evidence actually shows, outcome by outcome — and where the gap between “works in a lab animal” and “works in a human” still is.
💪 Muscle & Sarcopenia — The Strongest Evidence
The headline finding from Nature Metabolism: in humans, blood trigonelline levels are lower in people with sarcopenia and correlate positively with muscle strength and the energy output of muscle mitochondria. In aging male mice, dietary trigonelline enhanced muscle strength and prevented fatigue. In worms, it reduced age-related muscle wasting. This muscle angle is the most directly relevant to human aging — and the most likely to eventually be tested in a proper human trial (PMID 38504132).
🐛 Lifespan (Worms) — Real, But Preclinical Only
In C. elegans roundworms, 50 µM trigonelline extended lifespan by about 17.9% and improved resistance to oxidative, heat, and pathogen stress. Notably, it did not extend lifespan in already-long-lived mutant worms — a sign it works through the same energy/nutrient pathways those mutants already activate (PMID 34616504).
🧠 Brain & Cognition — Early Promise in Mice
In the SAMP8 mouse — a model of accelerated aging that mimics age-related cognitive decline — 30 days of trigonelline (5 mg/kg/day) improved memory and spatial learning, cut inflammatory cytokines, and boosted key neurotransmitters in the hippocampus, the brain’s memory center (PMID 37721682).
❤️ Blood Vessels — Mixed Human Data (The Honest Part)
Here the story gets genuinely mixed. In healthy adults, eating 170 g/day of trigonelline-rich Sakurajima radish for 10 days improved flow-mediated dilation (a measure of artery flexibility) and raised blood trigonelline (PMID 40903243). But in a 2026 Phase IIb trial of 21 patients with metabolic syndrome, the same radish did not improve artery function, and it unexpectedly increased oxidative stress and raised systolic blood pressure by ~9 mmHg (PMID 42280444). That’s a caution flag — not proof of harm, but a reason not to assume “natural NAD⁺ booster = automatically safe for everyone.”
👶 Ovarian Aging — Intriguing, Preclinical
In aging mice, trigonelline activated NRF2 to “wake up” dormant ovarian follicles, improved egg quality, and — in human ovarian tissue — increased follicle activation (PMID 41210958). This is a genuine anti-aging angle, but it is years from any fertility recommendation.
🫘 Liver, Kidney & Metabolic Health — Supporting, Preclinical
Trigonelline protected mouse kidneys from sepsis injury via NAD⁺/SIRT1 (PMID 40698661) and synergized with the mTOR drug everolimus to reduce liver inflammation and fibrosis in a mouse NASH model (PMID 40686355). A 2026 systematic review of 231 preclinical studies concluded fenugreek’s compounds (trigonelline + diosgenin) show consistent antioxidant and anti-aging effects — but flagged the near-total absence of clinical data (PMID 41941318).
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Membrez et al. (2024) Nature Metabolism |
Human cohorts + worms + mice + human cells | Trigonelline is an NAD⁺ precursor via the Preiss-Handler pathway; lower in human sarcopenia; improves muscle strength in aging mice. |
| Zeng et al. (2021) Oxid Med Cell Longev |
C. elegans worms | 50 µM trigonelline extended worm lifespan ~17.9%; depended on AMPK (aak-2), FOXO (daf-16), and HSF-1. |
| Aktar et al. (2024) GeroScience |
SAMP8 accelerated-aging mice, 30 days | 5 mg/kg/day improved memory, cut TNFα/IL-6, and raised dopamine/noradrenaline/serotonin in the brain. |
| Tokushige et al. (2026) Nutrients |
Phase IIb human RCT, 21 patients (crossover) | Trigonelline-rich radish did NOT improve artery function in metabolic syndrome; raised systolic BP (~+9 mmHg) and oxidative stress. |
| Kajiya et al. (2025) J Smooth Muscle Res |
Human trial, healthy adults | 170 g/day Sakurajima radish for 10 days improved artery flexibility (FMD) and raised blood trigonelline in healthy people. |
| Amoushahi et al. (2025) iScience |
Aged mice + human ovarian tissue | Trigonelline activates NRF2 to awaken dormant ovarian follicles and improve egg quality in aged mice. |
| Shahrahmani et al. (2026) Curr Drug Res Rev |
Systematic review (231 preclinical studies) | Fenugreek’s trigonelline + diosgenin show consistent antioxidant/anti-aging effects; clinical data almost entirely lacking. |
Dosing and Safety
Recommended Form
There is no established human dose, so be honest with yourself about what you’re buying. Trigonelline is sold two ways: as pure trigonelline (capsules, often 250–500 mg) and as standardized fenugreek seed extract (which contains trigonelline plus diosgenin and other compounds). If your goal is the NAD⁺/muscle mechanism from the 2024 study, look for a product that states its trigonelline content in milligrams — not a vague “fenugreek extract.”
Dosing Protocol
| Goal | Daily Dose | Notes |
|---|---|---|
| Food-level (coffee) intake | ~50–200 mg (1–3 cups) | What most people already get; covers the lower animal-scaled dose (~28 mg for a 70 kg adult). |
| Supplement range (speculative) | 250–1000 mg | Common in commercial products; based on scaling animal doses up, not on a human trial. Start low. |
| Timing | Morning, with food | No formal timing data; taking with a meal is reasonable since it’s a water-soluble compound usually consumed with food. |
Safety and Side Effects
| Concern | Details |
|---|---|
| Overall tolerability | Generally well-tolerated at food doses (it’s in coffee). Long-term safety of high-dose supplements is unstudied. |
| Blood-pressure caution | The 2026 metabolic-syndrome trial saw a ~9 mmHg rise in systolic BP and higher oxidative stress — reason for caution in people with high blood pressure, diabetes, or metabolic syndrome. |
| Blood-sugar interaction | Fenugreek (a major source) can lower blood sugar — it may add to the effect of diabetes drugs and cause hypoglycemia. |
| Blood-thinner interaction | Fenugreek has mild anticoagulant properties; caution with warfarin and other blood thinners. |
| Pregnancy & breastfeeding | Fenugreek is a traditional uterine stimulant; avoid high-dose supplements during pregnancy. No safety data for isolated trigonelline. |
🥦 Food Sources & Equivalents
The honest answer up front: ⚠️ Food helps — coffee is a genuine, meaningful source — but a supplement tops up if you want the higher, controlled doses.
Can you get it from food?
Yes, and more realistically than for most longevity compounds. Coffee is the big one: a brewed cup delivers roughly 40–110 mg of trigonelline (Arabica beans are higher than Robusta, and decaf keeps most of it). Fenugreek seeds are even richer (about 1–2% by weight), and smaller amounts sit in peas, barley, corn, and spinach.
| Food | Rough amount of trigonelline |
|---|---|
| Brewed coffee (1 cup) | ~40–110 mg (Arabica higher; decaf similar) |
| Fenugreek seeds (1 g) | ~10–20 mg |
| Sakurajima radish (170 g serving) | High (the exact amount used in human trials) |
| Peas, barley, corn, spinach | Small amounts (a few mg per serving) |
How much food equals the research dose?
The mouse dose of 5 mg/kg/day scales to roughly 28 mg per day for a 70 kg adult — which is covered by about half a cup to one cup of coffee. So a habitual coffee drinker is already getting a research-relevant amount. The catch: the higher supplement doses (500–1000 mg) would take 5–10 cups of coffee or 25–100 grams of fenugreek a day — not realistic (and that much coffee brings its own caffeine problems).
The bottom line
⚠️ Food helps, supplement tops up. If you drink coffee daily, you’re already getting meaningful trigonelline — one of the few longevity compounds where “just eat/drink it” is genuinely plausible for the lower dose range. A supplement is only worth it if you want a standardized, higher dose and you’re comfortable with the fact that the human evidence is still thin and mixed.
❓ Common Questions About Trigonelline
What is trigonelline and how does it work?
Trigonelline is a natural compound in coffee and fenugreek that is a close cousin of niacin (vitamin B3). Your body strips off a small chemical tag and turns it into NAD⁺, the fuel molecule that declines with age — using a different route than popular supplements like NMN and NR. That NAD⁺ boost, plus effects on antioxidant and anti-inflammatory switches, is thought to explain its benefits.
What does the evidence actually show?
The strongest evidence is a 2024 landmark study showing trigonelline raises NAD⁺ in human cells, worms, and mice, that people with age-related muscle loss have less of it, and that it improves muscle strength in aging mice. In worms it extends lifespan about 18%. But human trial evidence is thin and mixed — one small trial showed a blood-vessel benefit in healthy people, while another found no benefit and a rise in blood pressure in people with metabolic syndrome.
What’s the right dose?
There is no established human dose. A cup of coffee provides about 40–110 mg, which already covers the lower dose scaled from animal studies (about 28 mg for a 70 kg adult). Commercial supplements typically provide 250–1000 mg per day, taken with food, but that range is based on scaling animal doses, not on a human trial. If you supplement, start at the low end.
What are the risks and side effects?
At food doses (from coffee) trigonelline is well-tolerated — billions of people consume it daily. The main concern comes from one 2026 human trial in people with metabolic syndrome, where a trigonelline-rich food raised systolic blood pressure by about 9 mmHg and increased oxidative stress. Fenugreek, a common source, can also lower blood sugar and mildly thin the blood.
Who should avoid it?
People with high blood pressure, diabetes, or metabolic syndrome should be cautious, given the blood-pressure signal in the metabolic-syndrome trial. Anyone on diabetes medication or blood thinners should talk to a doctor first, because fenugreek can interact with both. Pregnant women should avoid high-dose fenugreek supplements, since it’s a traditional uterine stimulant.
The Bottom Line
Evidence Hierarchy
Trigonelline sits in an interesting position: its mechanism is better established in humans than most supplements’ — a Nature Metabolism paper used isotope labeling to prove human cells convert it into NAD⁺, and tied low blood levels to sarcopenia in real patients. That’s a stronger mechanistic foundation than most “longevity” products ever get.
But the outcome evidence is still early. The longevity data is worms; the muscle data is mice; the human data is observational (sarcopenia correlation) plus two small, short, conflicting food trials — including one that raised a genuine blood-pressure caution in people with metabolic syndrome. There is no trial showing a trigonelline supplement improves muscle, strength, or any aging outcome in healthy humans.
Our Verdict
For longevity, the honest label is “promising NAD⁺ mechanism, unproven human benefit.” The 2024 study is genuinely exciting and has launched a wave of research. But excitement is not the same as evidence of benefit.
If you want to try it: the lowest-risk version is simply drinking coffee — you’ll get a research-relevant dose for free, and coffee itself has strong longevity epidemiology. If you want a supplement, a product that states its trigonelline content (250–500 mg to start) is the reasonable version, but know you’re making a bet on unproven human benefit — and skip it if you have high blood pressure or metabolic syndrome.
If you’re chasing NAD⁺ for longevity: remember the free options first — exercise and good sleep raise NAD⁺-linked pathways without a pill, and the entire NAD⁺-precursor field (NMN, NR, niacin, and now trigonelline) still lacks a single definitive human longevity result.
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Trigonelline and fenugreek can interact with diabetes medication and blood thinners, and one human trial reported increased blood pressure in people with metabolic syndrome. Always consult your healthcare provider before starting any new supplement — especially if you are pregnant, nursing, have high blood pressure, diabetes, or take prescription medication.
Sources
- Membrez M, Migliavacca E, Christen S, et al. Trigonelline is an NAD⁺ precursor that improves muscle function during ageing and is reduced in human sarcopenia. Nat Metab. 2024. PMID: 38504132
- Zeng L, Tan J, Han R, et al. Trigonelline Extends the Lifespan of Caenorhabditis elegans through the DAF-16/HSF-1 Signaling Pathway. Oxid Med Cell Longev. 2021. PMID: 34616504
- Aktar S, Ferdousi F, Kondo S, et al. Transcriptomics and biochemical evidence of trigonelline ameliorating learning and memory decline in the senescence-accelerated mouse prone 8 (SAMP8) model. GeroScience. 2024. PMID: 37721682
- Tokushige A, Akasaki Y, Shibata K, et al. Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial. Nutrients. 2026. PMID: 42280444
- Kajiya K, Kuroda T, Sasaki M, et al. Effects of Sakurajima-radish and trigonelline on nitric oxide (NO) production from vascular endothelial cells and human vascular endothelial function. J Smooth Muscle Res. 2025. PMID: 40903243
- Amoushahi M, Ernst EH, Heuck A, et al. Trigonelline activates NRF2 and awakens dormant ovarian follicles to promote pregnancy in aging mice. iScience. 2025. PMID: 41210958
- Lv X, Cao Y, Yang Y, et al. Trigonelline attenuated sepsis-induced acute kidney injury by activating NAD⁺/SIRT1 Pathway. Physiol Res. 2025. PMID: 40698661
- Peerapen P, Boonmark W, Chantarasaka K, et al. Trigonelline prevents high-glucose-induced endothelial-to-mesenchymal transition, oxidative stress, mitochondrial dysfunction, and impaired angiogenic activity in human endothelial cells. Biomed Pharmacother. 2024. PMID: 39191024
- Sharma A, Sharma A, Rashid S, et al. Co-treatment of trigonelline and everolimus synergistically prevented chronic steatohepatitis induced by fast food diet and thioacetamide in a novel murine NASH model. Indian J Pharmacol. 2025. PMID: 40686355
- Shahrahmani M, Ahansazan S, Kalantari E, et al. Fenugreek (Trigonella foenum-graecum) and its Active Compounds, Diosgenin and Trigonelline, in the Prevention of Cancer and Aging: A Systematic Review of Preclinical Studies. Curr Drug Res Rev. 2026. PMID: 41941318
- Jiang Y, Ding X. Coffee as a polypharmacological modulator of mitochondrial health: from molecular mechanisms to translational implications. J Transl Med. 2026. PMID: 42469894